The US Federal Court overturned a previous ruling in the patent infringement cas...
The Centre for Advanced Imaging (CAI) of the University of Queensland in Austral...
Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alz...
In the latest edition of STAT's Health Tech newsletter: Better Therapeutics race...
Criegee intermediates are produced in the ozonolysis of unsaturated compounds in...
Tokyo, Japan – Scientists from Tokyo Metropolitan University have shown that 5-a...
The discovery that football players were unknowingly acquiring permanent brain d...
The European university network Enlight has been renewed: the EU has funded the ...
Incyte is attempting to enter the competitive market for atopic dermatitis with ...
After an initial deal of $81 million in June 2022, Novartis and Samsung have dec...
After experiencing trouble with observations in February, Outset Medical has rec...
Causaly serves 12 of the top 20 pharmaceutical companies with technology that ai...
Yusimry is priced at $995 per carton of two autoinjectors compared to Humira’s p...
After a call to action on social media, J&J has allowed the generic production o...
CureVac adds one more patent to the growing tally in its counterclaim against Pf...
Theseus Pharmaceuticals has terminated its pan-variant tyrosine kinase receptor ...
